Evidence map›Paper›PMID 28005153›Full record

Trial reportDer Urologe. Ausg. A2017

[Significance of PSMA imaging in prostate cancer].

C Gasch, C Düwel, K Kopka, C Kratochwil, M Vinsensia, M Eiber, T Maurer, U Haberkorn, B Hadaschik, F L Giesel

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Der Urologe. Ausg. A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. European journal of nuclear medicine and molecular imaging · 2019
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

C GaschUrologische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
C DüwelUrologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Deutschland.
K KopkaAbteilung Radiopharmazeutische Chemie, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland.
C KratochwilAbteilung Nuklearmedizin, Radiologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.
M VinsensiaAbteilung Nuklearmedizin, Radiologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.
M EiberNuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Deutschland.
T MaurerUrologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Deutschland.
U HaberkornAbteilung Nuklearmedizin, Radiologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.
B HadaschikUrologische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
F L GieselAbteilung Nuklearmedizin, Radiologische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. frederik@egiesel.com.
University Hospital Heidelberg · DETechnical University of Munich · DEDKFZ-ZMBH Alliance · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate cancer (PCa) is one of the most common malignancies of men in developed countries. To improve clinical diagnostics of PCa,

objectivesTo analyse the current significance of MATERIALS AND

methodsRetrospective analysis of current literature (PubMed search) regarding

resultsCompared to conventional imaging,

conclusionsDue to the excellent results of

Indexed as

Organometallic CompoundsEdetic AcidEvidence-Based MedicineGallium IsotopesGallium RadioisotopesHumansMaleOligopeptidesProstateProstatic NeoplasmsRadiopharmaceuticalsReproducibility of ResultsSensitivity and SpecificityEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesOrganometallic CompoundsRadiopharmaceuticalsBiochemical recurrenceMultiparametric magnetic resonance imagingPositron emission tomographyProstate specific membrane antigenStaging

Identifiers

PMID28005153
OpenAlexW2562778591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.